Manual Lymphatic Drainage Before and After Total Knee Replacement, a Single-center Observer-blinded Randomized Controlled Trial

Sponsor
Moritz Wagner (Other)
Overall Status
Recruiting
CT.gov ID
NCT05119764
Collaborator
Bezirkskrankenhaus St. Johann in Tirol (Other)
150
1
3
24
6.3

Study Details

Study Description

Brief Summary

The aim of this observer-blinded randomized controlled trial is the evaluation of the influence of manual lymphatic drainage (MLD) on the outcome of patients receiving total knee replacement (TKA).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Manual Lymphatic Drainage
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial with three treatment groups, two intervention groups and one control groupRandomized controlled trial with three treatment groups, two intervention groups and one control group
Masking:
Single (Investigator)
Masking Description:
Observer/Investigators are unaware of the treatment arm of each patient. Patients cannot be blinded, due to the obvious treatment intervention (manual lymphatic drainage 15 minutes for 5 days).
Primary Purpose:
Treatment
Official Title:
Manual Lymphatic Drainage Before and After Total Knee Replacement, a Single-center Observer-blinded Randomized Controlled Trial
Actual Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Feb 28, 2022
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control Group

Standard pre- and postoperative physical therapy without manual lymphatic drainage.

Experimental: Manual lymphatic drainage before and after knee replacement

Manual lymphatic drainage before and after knee replacement

Procedure: Manual Lymphatic Drainage
Manual Lymphatic Drainage is a form of physical therapy with the primary goal of accelerating lymphatic drainage. In this study, the manual lymphatic drainage is applied by experienced physical therapists 5 days in a row for 30 minutes each; after and/or before the surgery.

Experimental: Manual lymphatic drainage after knee replacement

Manual lymphatic drainage after knee replacement

Procedure: Manual Lymphatic Drainage
Manual Lymphatic Drainage is a form of physical therapy with the primary goal of accelerating lymphatic drainage. In this study, the manual lymphatic drainage is applied by experienced physical therapists 5 days in a row for 30 minutes each; after and/or before the surgery.

Outcome Measures

Primary Outcome Measures

  1. Swelling [Change in swelling weeks before the operation to one year after the operation]

    The swelling/volume is calculated through measurements of the circumference at 7 distinct points of the leg. The unit is [mm].

  2. Function [Change in ROM weeks before the operation to one year after the operation]

    Knee range of motion (ROM), active and passive. The unit is [degrees]

  3. Pain [Change in pain weeks before the operation to one year after the operation]

    Visual analogue scale from 0 to 10 on the average level of pain in the last 24 hours with 0 meaning no pain and 10 meaning most severe pain. The unit is [n](0 best-10 worst)

Secondary Outcome Measures

  1. Subjective patient reported outcome [Before the operation, five days after the operation and one year after the operation]

    WOMAC Score (Western Ontario and McMaster University Osteoarthritis Index)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Total Knee Arthroplasty (TKA)
Exclusion Criteria:
  • Venous insufficiency

  • BMI > 38

  • Vascular disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 BKH St. Johann in Tirol Sankt Johann In Tirol Tyrol Austria 6380

Sponsors and Collaborators

  • Moritz Wagner
  • Bezirkskrankenhaus St. Johann in Tirol

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Moritz Wagner, Principal Investigator, Dr. med. univ. Moritz Wagner, Bezirkskrankenhaus St. Johann in Tirol
ClinicalTrials.gov Identifier:
NCT05119764
Other Study ID Numbers:
  • 1466/2020
First Posted:
Nov 15, 2021
Last Update Posted:
Nov 15, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2021